Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Merck & Co., Inc.

Merck & Co., Inc. (MRK) Stock Overview

Explore Merck & Co., Inc.’s financial performance, market position, analyst ratings, and future outlook.

MRK●NYSE
HealthcareDrug Manufacturers - General
$126.26
$1.86(1.50%)
U.S. Market opens in 15h 48m

Merck & Co., Inc. (MRK)

Meyka AI Score

Z

Key Financials

Market Cap311.9B
P/E Ratio35.08
EPS (TTM)$5.47
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 Month$126.37
3 Months$123.41
1 Year Target$145.49

MRK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Merck & Co., Inc. (MRK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.20, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $145.49.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.08 and a market capitalization of 311.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.50%
5-Day Change
1.56%
1-Month Change
9.34%
3-Month Change
12.18%
6-Month Change
13.64%
Year-to-Date (YTD) Change
19.96%
1-Year Change
59.21%
3-Year Change
14.39%
5-Year Change
65.30%
All-Time (Max) Change
31837.17%

Contact Information

https://www.merck.com
908 740 4000
126 East Lincoln Avenue, Rahway, NJ, 07065

Company Facts

750,000 Employees
IPO DateJan 13, 1978
CountryUS
Actively Trading

Frequently Asked Questions